Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2018

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Shelley Wood

October 12, 2018

News Conference News TCT 2018

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

Michael O'Riordan

October 02, 2018

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

Yael L. Maxwell

September 23, 2018

Presentation TCT 2018

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

Presenter: Horst Sievert, Brian K. Whisenant, Jeffrey J. Popma

September 23, 2018

News Conference News TCT 2018

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Shelley Wood

September 23, 2018

News Conference News TCT 2018

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Michael O'Riordan

September 22, 2018

News Opinion Off Script TCT 2018

Off Script: Sharing, Caring, and Daring to Dream

Kwan S. Lee

September 22, 2018

Presentation TCT 2018

CvLPRIT: Long-term Follow-up From a Randomized Trial of Early Complete Revascularization in Patients With Acute Myocardial Infarction and Multivessel Disease

Presenter: Jonathan M. Hill, E. Magnus Ohman, Anthony H. Gershlick

September 22, 2018

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

News Conference News TCT 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

Todd Neale

September 21, 2018

Presentation TCT 2018

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Presenter: Antonio L. Bartorelli, David G. Rizik, Dean J. Kereiakes

September 21, 2018

Advertisement

My Takeaways From TCT 2018: Sunglasses, Shadows, and the COAPT Eclipse

Twitter, Bias, and Trial Tweaks: ISCHEMIA Invites Debate on Study Designs and Endpoint Combos

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

REDUCE-FMR: Percutaneous Annuloplasty Reduces Regurgitation in Heart Failure Patients With Functional MR

SURTAVI: Two-Year Complete Results From a Randomized Trial of a Self-Expanding Transcatheter Heart Valve vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk

COAPT: MitraClip Reduces Repeat Hospitalizations, Mortality in Functional MR Patients With Severe HF

Resolute Onyx Fares Well Against Thin-Strut Orsiro Stent in BIONYX All-Comers Study

Off Script: Sharing, Caring, and Daring to Dream

CvLPRIT: Long-term Follow-up From a Randomized Trial of Early Complete Revascularization in Patients With Acute Myocardial Infarction and Multivessel Disease

Novel LAA Closure Device Shows Promise in Early Experience

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

TCT-61: Clinical Outcomes Following Complete Bioresorption of the Absorb Everolimus-Eluting Bioresorbable Scaffold: Four-year Results from the ABSORB III Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content